top of page

Medication middlemen face bipartisan criticism as Congress eyes industry reforms

Executives from three of the largest pharmacy benefit managers (PBMs) pushed back against bipartisan criticism during a House Oversight Committee hearing Tuesday where lawmakers faulted the industry for high drug prices. ...


Comments


bottom of page